Dr. Jorge C. Busse, MD

Dr. Busse practices at Nephrology Associates of South Miami PA in Miami, Florida.

Dr. Busse's NPI, 1922091248, was assigned on August 23, 2005. Dr. Busse graduated from Universidad Central del Este Facultad de Medicina in 1980. Dr. Busse holds Florida license ME0043751.

Dr. Busse's primary practice is Nephrology Associates of South Miami PA, at 9193 SW Sunset St, Miami, FL 33173 in Miami-Dade County. The practice phone is (305) 273-9377.

Dr. Busse's primary practice is Nephrology Associates of South Miami PA in Miami, Florida. Dr. Busse is also affiliated with Baptist Health Mariners Hospital. The medical group on file is Kidney Specialists in Miami. Dmand AI also links Dr. Busse to 2 more dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Busse practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Busse's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Busse is board certified in internal medicine by the American Board of Internal Medicine. Dr. Busse is licensed in Florida.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Busse treats.

CMS data shows 478 Medicare services from Dr. Busse across 3 procedure codes in 2024, for 207 Medicare patients. Medicare paid $34,862 for them. Every service was in an office.

CMS counts 207 Medicare patients who saw Dr. Busse in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Busse's median patient age at 76, with 43% women.

In 2024, Dr. Busse wrote 3,798 Medicare Part D claims for 488 patients. 77% of them were for generic drugs. CMS names the drug for 3,469 of them, across 43 drugs with 11 or more claims each, at $1,072,818 in total drug cost. In 2023, CMS named 3,211 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Busse for performance year 2024, reported as part of a group. Dr. Busse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Busse as offering telehealth.

Dmand AI links 2 papers to Dr. Busse.

CMS Open Payments shows 457 general payments to Dr. Busse from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Relypsa, Inc. paid the most, $31,086.

Dmand AI lists 5 awards for Dr. Busse, most recently Top Doctors:South Florida in 2012.

Dr. Busse graduated from Universidad Central del Este Facultad de Medicina in 1980. Dr. Busse is a member of ACP and Renal Physicians Association.

Dr. Busse is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.